CATALYST PHARMACEUTICALS INC

Ticker: CPRX CUSIP: 14888U101 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 27,056 Value ($000) $631 Avg Close $22.28 Range $19.90 - $25.14

Q3 2025

Shares 21,065 Value ($000) $415 Avg Close $20.57 Range $19.05 - $22.53

Q2 2025

Shares 18,176 Value ($000) $394 Avg Close $23.61 Range $20.40 - $26.58

Q4 2024

Shares 12,817 Value ($000) $267 Avg Close $21.48 Range $19.54 - $24.27

Q3 2024

Shares 20,069 Value ($000) $399 Avg Close $18.54 Range $14.97 - $21.67

Q2 2024

Shares 29,808 Value ($000) $462 Avg Close $15.57 Range $14.47 - $17.03

Q4 2023

Shares 32,992 Value ($000) $555 Avg Close $13.67 Range $11.55 - $17.40

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	27,056	$631	$22.28	$19.90 - $25.14
Q3 2025	21,065	$415	$20.57	$19.05 - $22.53
Q2 2025	18,176	$394	$23.61	$20.40 - $26.58
Q4 2024	12,817	$267	$21.48	$19.54 - $24.27
Q3 2024	20,069	$399	$18.54	$14.97 - $21.67
Q2 2024	29,808	$462	$15.57	$14.47 - $17.03
Q4 2023	32,992	$555	$13.67	$11.55 - $17.40